Marcello F. Lingua
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.
Journal: Cancers
Published: April 20, 2021
Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 01, 2021
IκBα targeting promotes oxidative stress-dependent cell death.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 30, 2020
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa.
Journal: Cellular and molecular life sciences : CMLS
Published: February 06, 2020
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets.
Journal: Cancers
Published: January 21, 2020
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia.
Journal: Journal of cellular and molecular medicine
Published: July 03, 2019
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.
Journal: Oncoimmunology
Published: July 05, 2017
SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Journal: Cell cycle (Georgetown, Tex.)
Published: February 04, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026